| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |